{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:56Z","timestamp":1791919136073,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1421,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jacc.2009.05.062","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T05:26:28Z","timestamp":1254288388000},"page":"1434-1437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Early Statin Therapy in Acute Coronary Syndromes"],"prefix":"10.1016","volume":"54","author":[{"given":"David D.","family":"Waters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2009.05.062_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.2009.205","article-title":"Scientific evidence underlying the ACC\/AHA clinical practice guidelines","volume":"301","author":"Tricoci","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.062_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.04.093","article-title":"Statins in acute coronary syndromes: do the guideline recommendations match the evidence?","volume":"54","author":"Morrissey","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib4","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.062_bib5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.062_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2009.05.062_bib7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.062_bib8","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.062_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9149(00)01519-8","article-title":"Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)","volume":"87","author":"Fonarow","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jacc.2004.12.083","article-title":"American College of Cardiology's Guidelines Applied in Practice (GAP) Projects in Michigan, American College of Cardiology Foundation (Bethesda, Maryland) Guidelines Applied in Practice Steering Committee","volume":"46","author":"Eagle","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.amjcard.2007.04.023","article-title":"Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein > or = 100 mg\/dl versus <100 mg\/dl","volume":"100","author":"Spencer","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.062_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2005.05.007","article-title":"The changing face of cardiovascular risk","volume":"46","author":"Grundy","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.062_bib15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2009.05.062_bib16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2005.03.077","article-title":"Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib17","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/eurheartj\/ehi186","article-title":"High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial","volume":"26","author":"Olsson","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2009.05.062_bib18","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2007.03.102","article-title":"Safety and efficacy of atorvastatin-induced very low-density lipoprotein cholesterol levels in patients with coronary heart disease (a post hoc analysis of the Treating to New Targets [TNT] study)","volume":"100","author":"LaRosa","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","article-title":"Can low-density lipoprotein be too low?","volume":"46","author":"Wiviott","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2009.05.062_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2009.05.062_bib21","author":"Collins"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709023699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109709023699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:34:44Z","timestamp":1760013284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109709023699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":20,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0735109709023699"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2009.05.062","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Statin Therapy in Acute Coronary Syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2009.05.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}